BiomeTreasure™
A Multi-Omics–Based Microbiome Therapeutics Discovery Platform
ATG-BANKProprietary Therapeutic
Microbiome Strain
Library
Microbiome Strain
Library
ATG-DBIntegrated Microbiome
Database
Database
ATG-MINEMulti-Omics-Driven
Efficacy Evaluation
System
Efficacy Evaluation
System
ATG-FRUITScalable Manufacturing
Platform for Microbiome
Therapeutics
Platform for Microbiome
Therapeutics
ATG-BANK
Functionally Validated Microbiome Strain Library
- A curated library of functional microbiome strains selectively isolated from human-derived fermented foods
- Proprietary strain isolation and identification technologies enabling rapid and accurate characterization
- Safety profiles pre-validated at the strain level to minimize development risk
- Genomic analysis–based functional prediction to support therapeutic candidate discovery
ATG-DB
High-Quality Microbiome Database
-
An integrated database linking human microbiome
profiles with disease associations, incorporating
multi-omics datasets including genomics,
metabolomics, and transcriptomics -
A comprehensive knowledge base built through
extensive internal and external data integration
Therapeutic Candidate Strain Database
-
A curated database of therapeutic candidate strains
encompassing genomic, metabolic, and transcriptomic data -
Enables prediction of safety, functional efficacy,
and microbiome–host interactions
ATG-MINE
Multi-Omics–Driven Efficacy and Mechanism-of-Action Evaluation System
- An integrated evaluation system combining disease-relevant animal models with multi-omics analysis to assess the efficacy of therapeutic candidates
- Enables precise elucidation of mechanisms of action by applying multi-omics data across target pathways and biological responses
ATG-FRUIT
Scalable Manufacturing Platform for Microbiome Therapeutics
- A scalable manufacturing platform for large-scale production of microbiome-based therapeutic materials
- Development of strain-specific culture conditions based on genomic insights to enable optimized and reproducible production